Medical Foods Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Medical Foods Market Report is Segmented by Product (Powders, Pills, Liquids, and Other Products), Application (Attention-deficit/Hyperactivity Disorder (ADHD), Depression, Diabetic Neuropathy, Cancer, Alzheimer's Disorder, Metabolic Disorder, and Other Applications), Route of Administration (Oral and Enteral), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, and Other Distribution Channels), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Report Offers the Market Sizes and Forecasts in Value (USD) for the Above Segments.

Medical Foods Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Medical Foods Market Size

Medical Foods Market Summary
Study Period 2019 - 2030
Market Size (2025) USD 10.53 Million
Market Size (2030) USD 13.63 Million
CAGR (2025 - 2030) 5.30 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration High

Major Players

Medical Foods Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Medical Foods Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Medical Foods Market Analysis

The Medical Foods Market size is estimated at USD 10.53 million in 2025, and is expected to reach USD 13.63 million by 2030, at a CAGR of 5.3% during the forecast period (2025-2030).

Factors propelling market growth include the growing prevalence of chronic diseases, the rising geriatric population, and the increasing shift toward disease-specific formulas. Additionally, the activities of prominent players are expected to be significant factors for market growth.

The growing demand for chronic diseases, including cancer, Alzheimer's, and cardiovascular issues, is on the rise, fueled by sedentary lifestyles, poor dietary choices, and an aging demographic. Additionally, surging obesity rates and environmental factors play a role in this trend. As more individuals pursue effective management strategies for these ailments, the demand for specialized medical foods is anticipated to rise, highlighting substantial market opportunities. Additionally, as per the Alzheimer’s Disease Facts and Figures 2024 report, about 6.9 million people in the United States are living with Alzheimer’s in 2024, and this number is projected to reach 13 million by 2050.

As per the same source, the US population aged 65 and older continues to expand, and the number and proportion of the population diagnosed with Alzheimer's will also increase. Thus, patients with Alzheimer’s often require specific dietary interventions to manage symptoms and improve quality of life, which is expected to fuel the market for medical foods in the forecast period.

Additionally, as cancer cases rise, the demand for medical foods surges. These specialized nutritional solutions play a crucial role in helping patients manage symptoms, recover more effectively, and elevate their quality of life throughout treatment. For instance, according to the October 2023 report of Macmillan Cancer Support, the incidence of cancer in the United Kingdom is increasing very rapidly, and it was estimated that the number of people living with cancer in the United Kingdom was projected to grow from 3.5 million in 2025 to 4 million by 2030. Hence, with the global surge in cancer cases, the need for personalized nutritional interventions is set to increase, paving the way for significant opportunities in the medical foods industry.

Furthermore, the rising geriatric population is a significant factor driving the medical foods market, as older adults often require specialized nutritional support due to age-related health conditions. Conditions such as diabetes, heart disease, and cognitive decline necessitate tailored dietary interventions to manage these health challenges effectively. For instance, according to the Asian Bank Development (ADB), in May 2024, the population of individuals aged 60 and older in developing Asia-Pacific countries is anticipated to reach approximately 1.2 billion, nearly doubling by 2050. Therefore, as the elderly population grows, the demand for medical foods specifically designed to address their unique nutritional needs will increase. This trend presents a significant opportunity for market expansion and the development of innovative products that support healthy aging and enhance the quality of life for the geriatric demographic, which will further fuel market growth in the forecast period.

Manufacturers are actively focused on launching products and expanding new facilities in the market for global expansion. For instance, in November 2023, Danone introduced Fortimel, its first medical nutrition product for adults, in China. This product, classified as food for special medical purposes, is a crucial element of Danone's strategy in the Chinese market. The company seeks to utilize its scientific expertise across all life stages, with a particular emphasis on expanding the adult medical food segment.

Similarly, in September 2023, Danone unveiled a EUR 50 million (USD 55.81 million) expansion of its production facility in Opole, Poland. This strategic move is designed to cater to the surging global demand for medical nutrition. With chronic diseases on the rise and an aging population, Danone is positioning itself to strengthen its foothold in the medical foods market. The expansion is set to empower Danone to cater to patients worldwide.

Due to the aforementioned factors, such as the growing prevalence of chronic diseases, the rising geriatric population, and manufacturers increasingly focusing on launches and expansion, the market is expected to continue to grow over the coming years.

However, a lack of awareness about the benefits of medical foods presents a significant obstacle to the adoption of medical foods in the forecast period.

Medical Foods Industry Overview

The medical foods market is moderately fragmented in nature due to the presence of several companies operating globally as well as regionally. Major players in the market are focused on product launches and advancements to expand their presence in the global market. The competitive landscape includes an analysis of a few international and local companies that hold market shares and are well known, including Danone SA, Nestlé SA, Abbott, Fresenius Kabi AG, and Primus Pharmaceuticals Inc.

Medical Foods Market Leaders

  1. Danone S.A.

  2. Nestlé S.A.

  3. Abbott

  4. Fresenius Kabi AG

  5. Primus Pharmaceuticals Inc.

  6. *Disclaimer: Major Players sorted in no particular order
Medical Foods Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Medical Foods Market News

  • September 2024: Danone unveiled plans to make a EUR 20 million investment in its Lalru, Punjab, nutrition facility in India over the next four years. This investment aims to enhance Danone's production capabilities in early-life and medical nutrition product areas where the company holds a global leadership position.
  • May 2024: Danone invested EUR 70 million (USD 76 million) to enhance its Steenvoorde production facility in France. This investment aims to strengthen Danone's specialized nutrition category, particularly by optimizing the capacity for its oral nutrition supplements. With these upgrades, the facility is set to produce 20 million liters of nutrition products by 2026, catering to patients with critical health conditions, including cancer.

Medical Foods Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Prevalence of Chronic Diseases
    • 4.2.2 Rising Geriatric Population
    • 4.2.3 Increased Demand for Targeted Nutritional Interventions
  • 4.3 Market Restraints
    • 4.3.1 Lack of Awareness About Benefits of Medical Foods
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD)

  • 5.1 By Product
    • 5.1.1 Powder
    • 5.1.2 Pills
    • 5.1.3 Liquid
    • 5.1.4 Other Products
  • 5.2 By Application
    • 5.2.1 Attention-deficit/Hyperactivity Disorder (ADHD)
    • 5.2.2 Depression
    • 5.2.3 Diabetics Neuropathy
    • 5.2.4 Cancer
    • 5.2.5 Alzheimer's Disorder
    • 5.2.6 Metabolic Disorder
    • 5.2.7 Other Applications
  • 5.3 By Route of Administration
    • 5.3.1 Oral
    • 5.3.2 Enteral
  • 5.4 By Distribution Channel
    • 5.4.1 Hospital Pharmacy
    • 5.4.2 Retail Pharmacy
    • 5.4.3 Online Pharmacy
    • 5.4.4 Other Distribution Channels
  • 5.5 Geography
    • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
    • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle East and Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East and Africa
    • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Danone SA
    • 6.1.2 Nestle SA
    • 6.1.3 Abbott
    • 6.1.4 Targeted Medical Pharma Inc.
    • 6.1.5 Primus Pharmaceuticals Inc.
    • 6.1.6 Fresenius Kabi AG
    • 6.1.7 Mead Johnson & Company LLC
    • 6.1.8 Medtrition Inc.
    • 6.1.9 FrieslandCampina
    • 6.1.10 Morinaga Milk Industry
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape Covers- Business Overview, Financials, Products and Strategies, and Recent Developments.
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Medical Foods Industry Segmentation

As per the scope of the report, medical foods are specially formulated products designed to meet the dietary needs of individuals with specific medical conditions or diseases. They are intended to manage such conditions under medical supervision and provide essential nutrients that may be lacking in regular diets. Unlike standard foods or dietary supplements, medical foods are regulated as foods but require a physician’s recommendation for use. 

The medical foods market is segmented by product, application, route of administration, distribution channel, and geography. By product, the market is segmented into powders, pills, liquids, and other products. By application, the market is segmented into attention-deficit/hyperactivity disorder (ADHD), depression, diabetic neuropathy, cancer, Alzheimer's disorder, metabolic disorder, and other applications. By route of administration, the market is segmented into oral and enteral. By distribution channel, the market is segmented into hospital pharmacy, retail pharmacy, online pharmacy, and other distribution channels. By geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the market sizes and forecasts in value (USD) for the above segments.

By Product Powder
Pills
Liquid
Other Products
By Application Attention-deficit/Hyperactivity Disorder (ADHD)
Depression
Diabetics Neuropathy
Cancer
Alzheimer's Disorder
Metabolic Disorder
Other Applications
By Route of Administration Oral
Enteral
By Distribution Channel Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Other Distribution Channels
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Medical Foods Market Research FAQs

How big is the Medical Foods Market?

The Medical Foods Market size is expected to reach USD 10.53 million in 2025 and grow at a CAGR of 5.30% to reach USD 13.63 million by 2030.

What is the current Medical Foods Market size?

In 2025, the Medical Foods Market size is expected to reach USD 10.53 million.

Who are the key players in Medical Foods Market?

Danone S.A., Nestlé S.A., Abbott, Fresenius Kabi AG and Primus Pharmaceuticals Inc. are the major companies operating in the Medical Foods Market.

Which is the fastest growing region in Medical Foods Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Medical Foods Market?

In 2025, the North America accounts for the largest market share in Medical Foods Market.

What years does this Medical Foods Market cover, and what was the market size in 2024?

In 2024, the Medical Foods Market size was estimated at USD 9.97 million. The report covers the Medical Foods Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Medical Foods Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Medical Foods Industry Report

Statistics for the 2025 Medical Foods market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Medical Foods analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.